EUSA Pharma, Inc.
EUSA Pharma, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| International Registry for Patients With Castleman Disease | Castleman disease, Hemic and Lymphatic Diseases, Multi-centric Castleman's Disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, macular corneal dystrophy | Recruiting | Not stated | 2026-03-03 | NCT02817997 | |
| Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2025-07-08 | NCT06485947 |